瑞林B类型可减轻氧化应激,并提供脏保护
Haowen Fang1, Xiaodong Sun2, Yanting Ding3
1School of environmental and chemical engineering, Shanghai University, Shanghai, PR China.
Cellular signalling
|April 6, 2025
概括
瑞林B类比 (LB-A) 通过降低血糖和蛋白尿,有效治疗小鼠糖尿病病 (DKD). 通过Cxcl1通路,LB-A可以减轻氧化应激,从而提供潜在的脏保护.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 糖尿病病 (DKD) 是糖尿病的严重并发症,其特点是患病率和死亡率高.
- 迫切需要有效的DKD治疗策略,以预防疾病进展并改善患者的治疗结果.
研究的目的:
- 在糖尿病病 (DKD) 的小鼠模型中研究Loureirin B类似物 (LB-A) 的治疗潜力.
- 阐明LB-A对DKD施加保护作用的基本机制,重点关注氧化应激和信号通路.
主要方法:
- 在小鼠中使用LB-A治疗DKD.
- 评估生物化学标志物,包括禁食血糖和蛋白尿.
- 测量氧化酶和抗氧化剂氧化酶含量,以评估氧化应激.
- 在体外细胞实验中,研究Cxcl1/Cxcr2轴在高葡萄糖诱导的DKD和LB-A治疗效果中的作用.
主要成果:
- 在小鼠中,LB-A治疗显著阻止了DKD的进展,降低了血糖和蛋白尿.
- LB-A降低了氧化酶含量和增加了抗氧化剂氧化酶含量,降低了活性氧物种 (ROS) 水平和减轻了氧化应激.
- 调节Cxcl1信号通路被确定为LB-A脏保护作用的关键机制.
- 细胞实验证实,抑制Cxcl1/Cxcr2轴可以防止高葡萄糖诱导的DKD,并影响LB-A的治疗疗效.
结论:
- 在糖尿病病 (DKD) 中,LB-A 显示出显著的治疗潜力.
- 通过调节Cxcl1信号通路,LB-A可减轻DKD中的氧化应激和损伤.
- 这些发现支持LB-A作为DKD治疗的有希望的候选者,强调Cxcl1途径作为治疗点.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
331
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
331
01:25Antihypertensive Drugs: Direct Renin Inhibitors
456
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
456
01:22Heart Failure Drugs: Diuretics
298
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
298
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
406
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
406
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
414
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
414
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
548
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
548